Tregalizumab

From Wikipedia, the free encyclopedia
Tregalizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized
Target CD4
Clinical data
Legal status ?
Identifiers
CAS number 1207446-68-1 N
ATC code None
Chemical data
Formula ?
 N (what is this?)  (verify)

Tregalizumab is an immunomodulator. It binds to CD4.[1]

References

  1. World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information 24 (4). 


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.